Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Instil Bio, Inc. (TIL)

Compare
16.48
-0.32
(-1.90%)
At close: April 15 at 4:00:00 PM EDT
16.48
0.00
(0.00%)
After hours: April 15 at 4:05:04 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
56,048
56,048
87,157
203,291
155,560
Operating Income
-56,048
-56,048
-87,157
-203,291
-155,560
Net Non Operating Interest Income Expense
-2,005
-2,005
3,657
1,772
80
Other Income Expense
-16,082
-16,082
-72,587
-23,731
-1,275
Pretax Income
-74,135
-74,135
-156,087
-225,250
-156,755
Tax Provision
-408
--
--
-2,073
39
Net Income Common Stockholders
-74,135
-74,135
-156,087
-223,177
-156,794
Diluted NI Available to Com Stockholders
-74,135
-74,135
-156,087
-223,177
-156,794
Basic EPS
-11.39
--
-24.00
-34.40
-29.60
Diluted EPS
-11.39
--
-24.00
-34.40
-29.60
Basic Average Shares
6,510.14
--
6,503.91
6,475.63
5,299.66
Diluted Average Shares
6,510.14
--
6,503.91
6,475.63
5,299.66
Total Operating Income as Reported
-73,541
-73,541
-159,169
-226,458
-155,560
Total Expenses
56,048
56,048
87,157
203,291
155,560
Net Income from Continuing & Discontinued Operation
-74,135
-74,135
-156,087
-223,177
-156,794
Normalized Income
-56,642
-56,642
-84,075
-200,218.50
-156,794
Interest Income
6,987
6,987
8,866
3,655
80
Interest Expense
7,997
7,997
4,214
1,883
--
Net Interest Income
-2,005
-2,005
3,657
1,772
80
EBIT
-66,138
-66,138
-151,873
-223,367
-156,755
EBITDA
-62,528
-62,528
-147,117
-217,380
-154,003
Reconciled Depreciation
3,610
3,610
4,756
5,987
2,752
Net Income from Continuing Operation Net Minority Interest
-74,135
-74,135
-156,087
-223,177
-156,794
Total Unusual Items Excluding Goodwill
-17,493
-17,493
-72,012
-23,167
--
Total Unusual Items
-17,493
-17,493
-72,012
-23,167
--
Normalized EBITDA
-45,035
-45,035
-75,105
-194,213
-154,003
Tax Rate for Calcs
--
--
--
0
--
Tax Effect of Unusual Items
--
--
--
-208.50
--
12/31/2021 - 3/19/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HLVX HilleVax, Inc.
1.6500
-1.79%
 
SEER Seer, Inc.
2.1000
+0.48%
 
ANRO Alto Neuroscience, Inc.
2.3600
+13.46%
 
EPIX ESSA Pharma Inc.
1.6300
-1.21%
 
IPSC Century Therapeutics, Inc.
0.5010
+0.36%
 
TBPH Theravance Biopharma, Inc.
8.63
-1.15%
 
ASMB Assembly Biosciences, Inc.
9.81
-3.82%
 
SPRO Spero Therapeutics, Inc.
0.7444
+6.19%
 
VTYX Ventyx Biosciences, Inc.
1.1100
+0.91%
 
KZR Kezar Life Sciences, Inc.
4.1100
-4.86%